Leonabio

This study tests if a new combination of two drugs (lasofoxifene and abemaciclib) works better than a standard combo (fulvestrant and abemaciclib) for people with advanced ER+/HER2- breast cancer that has a specific gene change called ESR1 mutation. About 500 adults whose cancer …